Drug Information

General Information
Drug ID	DR01443
Drug Name	Norverapamil
Synonyms	Arverapamil; (R)-norverapamil; Agi-003; UNII-3J8P56R04P; (R)-(+)-Nor Verapamil Hydrochloride; 123932-43-4; 3J8P56R04P; Rezular; (+)-norverapamil; (R)-desmethylverapamil; (+)-desmethylverapamil; CHEBI:134082; ZINC13492624; AKOS030532539; Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, (alphaR)-; UNII-957Z3K3R56 component UPKQNCPKPOLASS-AREMUKBSSA-N
Drug Type	Small molecular drug
Indication	Irritable bowel syndrome [ICD11: DD91.0]				Phase 2	[1]
Formula	C26H36N2O4
Canonical SMILES	CC(C)C(CCCNCCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
InChI	InChI=1S/C26H36N2O4/c1-19(2)26(18-27,21-9-11-23(30-4)25(17-21)32-6)13-7-14-28-15-12-20-8-10-22(29-3)24(16-20)31-5/h8-11,16-17,19,28H,7,12-15H2,1-6H3
InChIKey	UPKQNCPKPOLASS-UHFFFAOYSA-N
CAS Number	CAS 67018-85-3
Pharmaceutical Properties	Molecular Weight		440.6	Topological Polar Surface Area	72.7
	Heavy Atom Count		32	Rotatable Bond Count	13
	Hydrogen Bond Donor Count		1	Hydrogen Bond Acceptor Count	6
XLogP	3.3
PubChem CID	104972
ChEBI ID	CHEBI:134080
TTD Drug ID	D0N1CH
DT(s) Transporting This Drug	P-GP	Transporter Info	P-glycoprotein 1		Substrate	[2]
References
1	Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313.
2	Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein. J Pharmacol Exp Ther. 2000 May;293(2):376-82.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.